Barrow, Hanley, Mewhinney & Strauss’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,983,270
Closed -$164M 356
2016
Q1
$164M Buy
2,983,270
+4,500
+0.2% +$245K 0.25% 79
2015
Q4
$184M Sell
2,978,770
-11,326
-0.4% -$714K 0.27% 73
2015
Q3
$189M Buy
2,990,096
+2,403
+0.1% +$172K 0.29% 68
2015
Q2
$218M Sell
2,987,693
-42,950
-1% -$3.1M 0.3% 74
2015
Q1
$198M Buy
3,030,643
+36,058
+1% +$2.4M 0.27% 77
2014
Q4
$195M Buy
2,994,585
+11,700
+0.4% +$754K 0.26% 77
2014
Q3
$179M Buy
2,982,885
+42,000
+1% +$2.74M 0.24% 77
2014
Q2
$204M Buy
2,940,885
+23,600
+0.8% +$1.53M 0.27% 76
2014
Q1
$191M Sell
2,917,285
-234,562
-7% -$15.3M 0.27% 74
2013
Q4
$195M Buy
3,151,847
+89,020
+3% +$5.15M 0.28% 73
2013
Q3
$164M Buy
3,062,827
+247,227
+9% +$12.7M 0.26% 70
2013
Q2
$128M Buy
+2,815,600
New +$122M 0.22% 77

Other funds holding STJ

Barrow, Hanley, Mewhinney & Strauss's STJ Position: Q2 2016 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 2,983,270 shares — an estimated $164M sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $218M in Q2 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 2,983,270 St Jude Medical shares in Q2 2016, an estimated $164M.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's St Jude Medical position peaked at $218M in Q2 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2016, filed 8 Aug 2016.